Gemcitabine, oxaliplatin, and paclitaxel (GOT) on a 2-weekly schedule in patients (pts) with refractory germ cell carcinoma: a phase II study conducted at the university of southern California
D. Quinn
Gemcitabine, oxaliplatin, and paclitaxel (GOT) on a 2-weekly schedule in patients (pts) with refractory germ cell carcinoma: a phase II study conducted at the university of southern California
D. Quinn